Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Franz Rischard (Tucson, United States of America), Franz Rischard, Roberto Bernardo, Rebecca Vanderpool, Aiden Abidov, Isaac Jenkins, Marc Simon, Lillian Hansen, Steve Knoper, Hunter Champion. Right ventricular (RV) morphometric and ventriculo-vascular (VV) coupling patterns in patients with advanced pulmonary arterial hypertension (PAH) undergoing parenteral treprostinil therapy. Eur Respir J 2015; 46: Suppl. 59, 2448

Member's Comments

No comment yet.

Related content which might interest you: Afterload reduction governs improvement in RV systolic function and ventriculo-arterial adaptation in patients with pulmonary arterial hypertension (PAH) undergoing rapid dose escalation of treprostinil Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Right ventricular function changes after therapy in chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension Year: 2016 Hemodynamic correlates of right ventricular afterload and pulmonary artery pulsatility under treatment with prostacyclin: Retrospective analysis of changes from baseline in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Amelioration of right ventricular morphology and systolic function in patients with severe group 3 pulmonary hypertension treated with pulmonary vasodilators Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Right ventricular (RV) diastolic function in patients with pulmonary hypertension (PH) due to chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 26s Year: 2002 Right ventricular MRI characteristics in patients with borderline pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Ratio of pulmonary arterial to aortic diameter and right to left ventricular diameter associate with poor outcome in medically-treated chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – A more functional view of chest pathology Year: 2015 Load-independent right ventricular function and idiopathic pulmonary arterial hypertension severity Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 The effect of treatment on right ventriculo-arterial coupling in idiopathic pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Left ventricular systolic torsion is correlated to right ventricular dilation in pulmonary hypertension patients Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Left ventricular-arterial coupling and cardiac remodeling in patients with idiopathic arterial pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Prognostic value of changes in radionuclide right ventricular ejection fraction in pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013 Right ventricular hypertrophy or dilatation in the pulmonary arterial hypertension: Is there a difference in the autonomic imbalance? Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013 Change in right atrial minimal volume is a prognostic marker in pulmonary arterial hypertension (PAH) Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH) Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014 Quantitative estimation of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension, receiving bosentan treatment Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 PAAT and RVET versus RVSP to predict pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010